Under the deal, Horizon's X-Man human discovery cell lines will be used to test the effects of common mutations in cancer patients on the efficacy of Mirna's miRNA mimics.
Full-text access for registered users only.
Existing users login here
New to GenomeWeb? Register here
quickly for free access.